Patent · US Active

Substituted imidazo[1,5-a]quinoxalin-4-ones as phosphodiesterase 9 inhibitors

US8674096B2 · kind B2 · utility

0Cited by
1References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 27, 2012
Grant dateMar 18, 2014
Priority date—
Expiry dateNov 27, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Substituted imidazo[1,5-a]quinoxalin-4-ones are useful as phosphodiesterase 9 inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.